Holen Sie sich die Stockscreener-App
16.04
25.42%
-5.465
Handel nachbörslich:
16.18
0.145
+0.90%
Schlusskurs vom Vortag:
$21.50
Offen:
$17.75
24-Stunden-Volumen:
10.57M
Relative Volume:
8.13
Marktkapitalisierung:
$2.06B
Einnahmen:
$2.89B
Nettoeinkommen (Verlust:
$-33.80M
KGV:
-59.39
EPS:
-0.27
Netto-Cashflow:
$204.10M
1W Leistung:
-26.11%
1M Leistung:
-18.77%
6M Leistung:
-27.64%
1J Leistung:
-47.18%
1-Tages-Spanne:
$15.95
$18.46
1-Wochen-Bereich:
$15.95
$22.29
52-Wochen-Spanne:
$15.95
$31.89
Surgery Partners Inc Stock (SGRY) Company Profile
Firmenname
Surgery Partners Inc
Sektor
Branche
Telefon
615-234-5900
Adresse
310 SEVEN SPRINGS WAY, BRENTWOOD, TN
Vergleichen Sie SGRY mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SGRY
Surgery Partners Inc
|
16.04 | 2.76B | 2.89B | -33.80M | 204.10M | -0.27 |
|
HCA
Hca Healthcare Inc
|
459.30 | 108.76B | 74.37B | 7.31B | 8.10B | 25.88 |
|
THC
Tenet Healthcare Corp
|
194.68 | 18.04B | 20.69B | 2.40B | 1.55B | 15.62 |
|
FMS
Fresenius Medical Care Ag Adr
|
23.70 | 13.91B | 21.23B | 924.30M | 2.22B | 1.2272 |
|
UHS
Universal Health Services Inc
|
222.63 | 14.59B | 16.08B | 1.20B | 1.06B | 17.82 |
|
EHC
Encompass Health Corp
|
115.17 | 11.60B | 5.51B | 494.70M | 386.40M | 4.84 |
Surgery Partners Inc Stock (SGRY) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-18 | Fortgesetzt | JP Morgan | Neutral |
| 2025-07-28 | Fortgesetzt | BofA Securities | Buy |
| 2024-12-16 | Eingeleitet | BofA Securities | Buy |
| 2024-10-14 | Eingeleitet | UBS | Buy |
| 2024-10-11 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2024-06-28 | Eingeleitet | Macquarie | Outperform |
| 2024-03-06 | Eingeleitet | Barclays | Equal Weight |
| 2023-11-14 | Hochstufung | TD Cowen | Market Perform → Outperform |
| 2023-06-02 | Hochstufung | BofA Securities | Neutral → Buy |
| 2023-05-12 | Eingeleitet | Mizuho | Buy |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2022-11-23 | Bestätigt | RBC Capital Mkts | Outperform |
| 2022-06-15 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-01-10 | Fortgesetzt | Citigroup | Buy |
| 2021-11-30 | Eingeleitet | Barclays | Overweight |
| 2021-11-29 | Hochstufung | Stifel | Hold → Buy |
| 2021-11-01 | Eingeleitet | JP Morgan | Neutral |
| 2021-10-18 | Eingeleitet | SVB Leerink | Outperform |
| 2021-09-10 | Eingeleitet | Cowen | Market Perform |
| 2021-06-23 | Fortgesetzt | Stifel | Hold |
| 2020-09-17 | Bestätigt | The Benchmark Company | Buy |
| 2020-04-27 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2020-03-03 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2020-01-14 | Bestätigt | The Benchmark Company | Buy |
| 2018-11-16 | Eingeleitet | UBS | Neutral |
| 2018-09-18 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2018-06-28 | Hochstufung | Stifel | Sell → Hold |
| 2018-01-30 | Bestätigt | The Benchmark Company | Buy |
| 2017-11-01 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2017-08-09 | Herabstufung | KeyBanc Capital Mkts | Overweight → Sector Weight |
| 2017-08-09 | Herabstufung | Raymond James | Strong Buy → Mkt Perform |
| 2017-08-09 | Herabstufung | Stifel | Hold → Sell |
| 2017-04-24 | Bestätigt | Stifel | Hold |
| 2017-03-10 | Herabstufung | Stifel | Buy → Hold |
| 2017-01-31 | Eingeleitet | The Benchmark Company | Buy |
| 2016-06-10 | Eingeleitet | KeyBanc Capital Mkts | Overweight |
| 2016-03-14 | Bestätigt | RBC Capital Mkts | Outperform |
| 2015-10-27 | Eingeleitet | Stifel | Buy |
| 2015-10-26 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2015-10-26 | Eingeleitet | Raymond James | Strong Buy |
Alle ansehen
Surgery Partners Inc Aktie (SGRY) Neueste Nachrichten
Decoding Surgery Partners Inc (SGRY): A Strategic SWOT Insight - GuruFocus
Surgery Partners Reports Q3 2025 Financial Results - TipRanks
Will Surgery Partners Inc. benefit from macro trendsJuly 2025 Highlights & Smart Swing Trading Alerts - newser.com
Surgery Partners Inc. Earnings Call: Mixed Results and Revised Guidance - TipRanks
Surgery Partners stock price target lowered to $24 by BofA Securities - Investing.com Nigeria
Surgery Partners revises 2025 outlook to $3.275B-$3.3B revenue amid capital deployment delays and volume softness - MSN
Why Surgery Partners Stock Plummeted on Monday - The Motley Fool
Why Surgery Partners Stock Plummeted on Monday - The Motley Fool
Surgery Partners Inc (SGRY) Q3 2025 Earnings Call Highlights: Strong Revenue Growth Amidst ... - Yahoo Finance
Surgery Partners price target lowered to $24 from $28 at BofA - TipRanks
Surgery Partners price target lowered to $28 from $30 at Jefferies - TipRanks
Strategic Divestitures and Financial Leverage: A Buy Rating for Surgery Partners - TipRanks
Surgery Partners, Inc. Provides Earnings Guidance for the Full Year of 2025 - MarketScreener
Surgery Partners Shares Fall After Q3 Results, Lowered Guidance - MarketScreener
Why Surgery Partners (SGRY) Stock Is Trading Lower Today - Yahoo Finance
Surgery Partners: Q3 Earnings Snapshot - Connecticut Post
Earnings call transcript: Surgery Partners Q3 2025 results miss expectations - Investing.com India
Surgery Partners Stock Tumbles Amid Leadership Shakeup - TipRanks
Surgery Partners Shares Plunge Over 11% After Slashing 2025 Guidance and Missing Q3 Estimates - MSN
Surgery Partners Q3 Adjusted Net Income Declines, Revenue Increases; 2025 Revenue Outlook Lowered - 富途牛牛
Surgery Partners (SGRY) Q3 Earnings and Revenues Lag Estimates - sharewise.com
Earnings call transcript: Surgery Partners Q3 2025 results miss expectations By Investing.com - Investing.com Canada
Surgery Partners stock hits 52-week low at $17.75 - Investing.com
Surgery Partners SGRY Q3 2025 Earnings Transcript - The Globe and Mail
Surgery Partners, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - MarketScreener
Surgery Partners Misses Estimates But Keeps Growth In Focus - Finimize
Can Surgery Partners Inc. stock sustain market leadershipTrade Risk Summary & Weekly High Potential Stock Alerts - newser.com
Surgery Partners Inc earnings missed by $0.08, revenue fell short of estimates - Investing.com
Surgery Partners shares tumble over 11% after 2025 guidance cut By Investing.com - Investing.com Philippines
Surgery Partners (NASDAQ:SGRY) Posts Q3 Sales In Line With Estimates But Stock Drops 13.5% - Yahoo Finance
Surgery Partners shares tumble over 11% after 2025 guidance cut - Investing.com
Earnings Flash (SGRY) Surgery Partners, Inc. Reports Q3 Revenue $821.5M, vs. FactSet Est of $820.0M - MarketScreener
Surgery Partners Reports Third Quarter 2025 Financial Results with Revenue Growth and Adjusted EBITDA Increase - Quiver Quantitative
Earnings Flash (SGRY) Surgery Partners, Inc. Posts Q3 Adjusted EPS $0.13 per Share, vs. FactSet Est of $0.20 - MarketScreener
Surgery Partners, Inc. Announces Third Quarter 2025 Results - The Manila Times
Surgery Partners misses Q3 revenue estimates, cuts FY forecast - MarketScreener
Is Surgery Partners Inc. stock attractive for income investors2025 Top Decliners & Entry Point Confirmation Alerts - newser.com
Applying sector rotation models to Surgery Partners Inc.2025 Top Gainers & Step-by-Step Trade Execution Guides - newser.com
Surgery Partners Inc. stock momentum explained2025 Top Gainers & Daily Profit Maximizing Tips - newser.com
Surgery Partners (SGRY): Examining Valuation Potential After Recent Share Rebound - simplywall.st
Surgery Partners (SGRY): Assessing Valuation After Recent Share Price Rebound - Yahoo Finance
Why Surgery Partners Inc. stock remains a top recommendationEarnings Growth Report & Safe Capital Growth Plans - newser.com
Using RSI to spot recovery in Surgery Partners Inc.Trade Ideas & Real-Time Chart Breakout Alerts - newser.com
Surgery Partners Earnings: What To Look For From SGRY - MSN
The Technical Signals Behind (SGRY) That Institutions Follow - news.stocktradersdaily.com
Surgery Partners Q3 2025 Earnings Preview - MSN
Developing predictive dashboards with Surgery Partners Inc. dataPortfolio Return Report & Step-by-Step Trade Execution Guides - newser.com
Why Surgery Partners Inc. stock is favored by top institutionsStop Loss & Short-Term High Return Strategies - newser.com
Is Surgery Partners Inc. meeting your algorithmic filter criteria2025 Valuation Update & High Yield Stock Recommendations - newser.com
Is Surgery Partners Inc. stock a top pick in earnings seasonEarnings Growth Report & Low Risk Entry Point Guides - newser.com
Finanzdaten der Surgery Partners Inc-Aktie (SGRY)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.23%
2.85%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):